dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Castro Marrero, Jesus |
dc.contributor.author | Segundo, Maria Jose |
dc.contributor.author | Lacasa, Marcos |
dc.contributor.author | Martínez Martínez, Alba |
dc.contributor.author | Sanmartín Sentañes, Ramón |
dc.contributor.author | Alegre Martin, José |
dc.date.accessioned | 2022-05-02T12:34:34Z |
dc.date.available | 2022-05-02T12:34:34Z |
dc.date.issued | 2021-08 |
dc.identifier.citation | Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Sentañes RS, Alegre-Martin J. Effect of dietary coenzyme q10 plus nadh supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: A prospective, randomized, double-blind, placebo-controlled trial. Nutrients. 2021 Aug;13(8):2658. |
dc.identifier.issn | 2072-6643 |
dc.identifier.uri | https://hdl.handle.net/11351/7429 |
dc.description | Coenzim Q10; Mitocondris; Encefalomielitis miàlgica |
dc.description.sponsorship | J.C.-M. received financial support and honoraria from Vitae Health Innovation Co., S.L. (Montmeló, Barcelona, Spain). This study was partially supported by the Vall d’Hebron Hospital Research Institute (Barcelona, Spain). Vitae Health Innovation Co. supplied both treatments (Coenzyme Q10 and NADH supplement tablets and placebo). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Nutrients;13(8) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Síndrome de fatiga crònica - Tractament |
dc.subject | Suplements nutritius |
dc.subject | Qualitat de vida - Avaluació |
dc.subject.mesh | Fatigue Syndrome, Chronic |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Dietary Supplements |
dc.subject.mesh | Quality of Life |
dc.title | Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/nu13082658 |
dc.subject.decs | síndrome de fatiga crónica |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | suplementos dietéticos |
dc.subject.decs | calidad de vida |
dc.relation.publishversion | https://doi.org/10.3390/nu13082658 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Castro-Marrero J, Sentañes RS, Alegre-Martin J] Unitat de Recerca d’Encefalomielitis Miàlgica/Síndrome de Fatiga Crònica, Divisió de Reumatologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Segundo MJ] Clinical Research Department, Vitae Health Innovation, Montmeló, 08160 Barcelona, Spain. [Lacasa M] Department of Education, Generalitat de Catalunya, Sabadell, 08202 Barcelona, Spain. [Martinez-Martinez A] Medical Oncology Clinical Trials Office, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 34444817 |
dc.identifier.pmid | 000690048200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |